Michael Neuenhahn
Overview
Explore the profile of Michael Neuenhahn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
1298
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Holle J, Reitmeir R, Behrens F, Singh D, Schindler D, Potapenko O, et al.
Am J Transplant
. 2025 Feb;
PMID: 39978595
Kidney transplantation (KT) is the best treatment for end-stage kidney disease, with graft survival critically affected by the recipient's immune response. The role of the gut microbiome in modulating this...
2.
Targeted T cell receptor gene editing provides predictable T cell product function for immunotherapy
Muller T, Jarosch S, Hammel M, Leube J, Grassmann S, Bernard B, et al.
Cell Rep Med
. 2021 Sep;
2(8):100374.
PMID: 34467251
Adoptive transfer of T cells expressing a transgenic T cell receptor (TCR) has the potential to revolutionize immunotherapy of infectious diseases and cancer. However, the generation of defined TCR-transgenic T ...
3.
Lahmer T, Kriescher S, Herner A, Rothe K, Spinner C, Schneider J, et al.
PLoS One
. 2021 Mar;
16(3):e0238825.
PMID: 33730058
Background: Superinfections, including invasive pulmonary aspergillosis (IPA), are well-known complications of critically ill patients with severe viral pneumonia. Aim of this study was to evaluate the incidence, risk factors and...
4.
Wagner L, Lanzl I, Rothe K, Schneider J, Zink A, Zapp D, et al.
Sex Transm Dis
. 2020 Nov;
48(6):436-442.
PMID: 33156290
Background: Data on ocular syphilis (OS) and its clinical presentation are currently insufficient. This study aimed to investigate the characteristics of a cohort with a high OS incidence at a...
5.
Kuhne J, Neudorfl C, Beushausen K, Keil J, Malysheva S, Wandrer F, et al.
Transpl Immunol
. 2020 Apr;
61:101291.
PMID: 32330566
Belatacept, Nulojix®, inhibits the interaction of CD28 on naïve T cells with B7.1/B7.2 (CD80/86) on antigen presenting cells, leading to T cell hyporesponsiveness and anergy and is approved as immunosuppressive...
6.
Schober K, Voit F, Grassmann S, Muller T, Eggert J, Jarosch S, et al.
Nat Immunol
. 2020 Mar;
21(4):434-441.
PMID: 32205883
Adaptive evolution is a key feature of T cell immunity. During acute immune responses, T cells harboring high-affinity T cell antigen receptors (TCRs) are preferentially expanded, but whether affinity maturation...
7.
Faist B, Schlott F, Stemberger C, Dennehy K, Krackhardt A, Verbeek M, et al.
PLoS One
. 2019 Oct;
14(9):e0223258.
PMID: 31568490
Adoptive T cell therapy (ACT) has become a treatment option for viral reactivations in patients undergoing allogeneic hematopoietic stem cell transplantation (alloHSCT). Animal models have shown that pathogen-specific central memory...
8.
Schlott F, Steubl D, Ameres S, Moosmann A, Dreher S, Heemann U, et al.
PLoS One
. 2018 Mar;
13(2):e0193554.
PMID: 29489900
Human Cytomegalovirus (CMV) reactivation remains a major source of morbidity in patients after solid organ and hematopoietic stem cell transplantation (HSCT). Adoptive T cell therapy (ACT) with CMV-specific T cells...
9.
Schlott F, Steubl D, Hoffmann D, Matevossian E, Lutz J, Heemann U, et al.
PLoS One
. 2017 Jan;
12(1):e0171035.
PMID: 28129395
Human Cytomegalovirus (CMV) can lead to primary infection or reactivation in CMV-seronegative or -seropositive kidney transplant recipients, respectively. Complications comprise severe end-organ diseases and acute or chronic transplant rejection. Risk...
10.
Keib A, Gunther P, Faist B, Halenius A, Busch D, Neuenhahn M, et al.
Viral Immunol
. 2017 Jan;
30(3):149-156.
PMID: 28085643
Infection with adenovirus is a major cause of infectious mortality in children following hematopoietic stem-cell transplantation. While adoptive transfer of epitope-specific T cells is a particularly effective therapeutic approach, there...